Cancer Vaccines Market for Dendritic Cells Cancer VaccinesSegment to Grow at Fastest CAGR during Forecast Period
According to our new market research study on “Cancer Vaccines Market to 2027 – South & Central America Analysis and Forecast – by Technology, Type, Indication, and End Use,”the market is expected to reach US$ 627.49million in 2027 from US$ 191.89million in 2019; it is estimated to grow at a CAGR of 16.3% from 2020 to 2027. The report highlights trends prevailing in the South & Central AmericaCancer Vaccines Market and the drivers and restraints pertaining to the market growth.
Based on technology, the Cancer Vaccines market is segmented into in dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, viral vector cancer vaccines. The in recombinant cancer vaccines segment held the largest share of the market in 2019. Moreover, recombinant cancer vaccines is estimated grow at the highest CAGR in the market during the forecast period.
Market growth in South & Central America Cancer Vaccines is mainly due to factors such as increasing prevalence of cancer and rising government initiatives to prevent cancer. However, challenges such as costly costs in the cancer vaccine industry restrict the growth of the market.
AstraZeneca, GlaxoSmithKline plc., Aduro Biotech Inc, Pfizer Inc., Sanofi, Bristol-Myers Squibb, Moderna, Inc., OncBioMune Pharmaceuticals Inc., MaxiVAX, Nouscomare among the leading companies operating in the Cancer Vaccines Market.
South & Central America Cancer Vaccines Market, By Country, 2019 (%) South and Central America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector Cancer Vaccines); Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); Indication (Cervical Cancer, Prostate Cancer, Other Indications); End User (Pediatrics, Adults), and Country
South & Central AmericaCancer Vaccines Market to Grow at a CAGR of 16.3% to reach US$ 627.49 Million from 2020 to 2027
Download Free Sample
The report segments South & Central AmericaCancer Vaccinesmarket as follows:
ByTechnology
- Dendritic Cells Cancer Vaccines
- Recombinant Cancer Vaccines
- Antigen Cancer Vaccines
- Whole Cell Cancer Vaccines
- Viral Vector Cancer Vaccines
By Type
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccine
By Indication
- Cervical Cancer
- Prostate Cancer
- Other Indications
By End-Use
- Pediatrics
- Adults
By Country
- Brazil
- Argentina
- RoSCAM